[New indications of protontherapy for adults intracranial tumours]

Cancer Radiother. 2021 Oct;25(6-7):545-549. doi: 10.1016/j.canrad.2021.06.009. Epub 2021 Jun 24.
[Article in French]

Abstract

Considering intracranial tumours, only few indications of protontherapy, such as chordoma, chondrosarcoma or uveal melanoma, are uniformly approved in the world. Other indications, excluding paediatric pathologies, are still debated. The aim of this article is to describe the rationale for the use of protonbeam irradiation for meningioma, pituitary adenoma, craniopharyngioma, paraganglioma, glioma, and schwannoma, and to inform the radiation oncologists if prospective studies or randomized studies are opened for inclusions. This article deals only with indications for adults.

Keywords: Adénome hypophysaire; Craniopharyngioma; Craniopharyngiome; Glioma; Gliome; Meningioma; Méningiome; Neurinome; Paraganglioma; Paragangliome; Proton therapy; Protonthérapie; Schwanomma; pituitary adenoma.

Publication types

  • Systematic Review

MeSH terms

  • Adenoma / radiotherapy
  • Adult
  • Brain Neoplasms / radiotherapy*
  • Chordoma / radiotherapy
  • Craniopharyngioma / radiotherapy
  • Glioma / radiotherapy
  • Humans
  • Meningeal Neoplasms / diagnostic imaging
  • Meningeal Neoplasms / radiotherapy*
  • Meningioma / diagnostic imaging
  • Meningioma / radiotherapy*
  • Neurilemmoma / radiotherapy
  • Paraganglioma / radiotherapy
  • Pituitary Neoplasms / radiotherapy*
  • Prospective Studies
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic